Rocket Labs Strategic Shift Raises Investor Uncertainty SP 500 Ekes Out Gains as Healthcare and Technology Lead Communication Services Lags Cheniere Energy Awards 469 Billion EPC Contract to Bechtel for LNG Expansion Retail Hiring Surge in April Contrasts with Cautious Consumer Signals Zelenskiy Reports Slow Progress in US Missile Defense Talks Defense Sector Weighted Standard Chartered to Cut Over 15 of Corporate Functions Roles in Efficiency Drive ALGM Q1 2026 Earnings EPS Beats Estimates by Nearly 2 Amidst Revenue Uncertainty AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs RANI Q1 2026 Earnings Narrowed Loss Beats Expectations as Pipeline Progress Continues GAIA Q1 2026 Earnings EPS Falls Short of Estimates Stock Rises 166 on Strategic Progress PPG Q1 2026 Earnings Earnings Beat Expectations Amid Operational Discipline EVLV Q1 2026 Earnings Narrow Loss Surprise Lifts Shares BIPJ Shares Advance 120 as FixedIncome Demand Strengthens Steven Madden SHOO Rebounds Analyzing the PostEarnings Momentum and Key Technical Levels St Joe Company JOE Nears Key Support as Volume Slips Technical Analysis FG Annuities 7300 Notes FGSN Dip Slightly as Yields Adjust Colony Bankcorp CBAN Holds Near Resistance as Volume Fades Pakistan to Deploy Paramilitary Force to Protect Strategic CopperGold Belt GrafTech International Ltd EAF Q1 2026 Earnings SteeperThanExpected Loss Weighs on Sentiment Despite Stock Gains Forafric Global Warrants AFRIW Consolidate Near Resistance at 080 Ballard Power Systems BLDP Q1 2026 Earnings Narrowing Loss Beats Estimates Shares Edge Higher Sonoco Products SON Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction NMRK Q1 2026 Earnings EPS Surpasses Estimates by 18 Stock Unchanged Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues SOPA Q3 2025 Earnings Significant EPS Miss Raises Concerns about Profitability COLB Q1 2026 Earnings Earnings Beat Driven by Strong Net Interest Income Shares Decline on Macro Concerns Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares